Unresectable cholangiocarcinoma – chemo/RT – pro

Lay Summary: Combined chemotherapy and radiation is reasonable option for unresectable disease but remians to be farther explored. Cholangiocarcinoma is a cancer of the bile ducts, which drain bile from the liver into the small intestine. It is a relatively rare cancer, with an annual incidence. If the tumor cannot be surgically removed, patients are often treated with palliative chemotherapy with or without radiotherapy. Chemotherapy has been shown

Read more
Routine MCP or ERCP surveillance for Cholagniocarcinoma or Liver Cancer in Patients with Primary Biliary Cirrhosis – pro

Primary sclerosing cholangitis (PSC) is a chronic, cholestatic liver disease characterized by inflammation and fibrosis of both intrahepatic and extrahepatic bile ducts. It is thoughtto be an immune mediated, progressive disorder that eventually develops into cirrhosis, portal hypertension and hepatic decompensation, in the majority of patients. Guidelines do not recommend routine MRCP or ERCP to screen for chalngiocarcinoma or hepatocellular carcinoma.

Read more